Grant, Allister J <br/><br/>
Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease.  [electronic resource] 

 -  The American journal of pathology  Apr 2002 
 - 1445-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9440 
<br/><br/><label>Standard No.: </label>10.1016/S0002-9440(10)62570-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Cells--physiology<br/>Cell Movement--physiology<br/>Cells, Cultured<br/>Chemokine CCL21<br/>Chemokines, CC--physiology<br/>Cholangitis, Sclerosing--metabolism<br/>Chronic Disease<br/>Humans<br/>Integrins--metabolism<br/>Liver--metabolism<br/>Lymphocytes--metabolism<br/>Lymphoid Tissue--pathology<br/>Portal System--pathology<br/>Receptors, CCR7<br/>Receptors, Chemokine--blood<br/>Reference Values<br/>T-Lymphocytes--physiology